论文信息 - A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer - 字舞流文

A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer

K. Gelmon | H. Rugo | G. Shapiro | G. Curigliano | A. Giordano | K. Kern | Z. Wainberg | M. Alsina | S. Leong | N. Pathan | K. Pierce | E. Stringer-Reasor | S. Mutka | U. Vaishampayan | M. Middleton | R. Kristeleit | A. A. Abdul Razak | A. Olszanski | R. Perea